Saturday 17 October 2026 Export ACAD’s income statement to Excel — free account

ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.1 billion, up 11.9% from fiscal 2024. In the quarter to June 2026, revenue grew 16.4%, EPS grew 12.5% and free cash flow grew 50.3%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.

19.12 0.59 −2.99%

Follow ACAD

Alert me

Market cap: $3.4B
P/E: 8.5×
Fwd P/E: 55.6×
Dividend yield: —
F-score: 6/9
Altman Z: 7.90
Beneish M: −0.89
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	34.95%	39.89%	37.32%	35.74%
Piotroski F-Score Full definition →		6	6	5	5
ROA Full definition →		22.64%	28.42%	27.44%	25.64%
ROIC Full definition →		214.34%	16.07%	12.75%	15.42%
Return on Tangible Assets Full definition →		36.10%	49.34%	46.66%	43.23%
Average Days of Receivables Full definition →		48.60	50.49	49.45	53.32
Free Cash Flow per Share Full definition →		0.00	0.62	0.67	0.85
Free Cash Flow Full definition →		0.06	104.69	113.59	145.63
Capital Expenditures Full definition →		(198.88)	(5.14)	(9.90)	(14.69)
Other line items
Cash ROIC Full definition →		0.00%	5.11%	5.41%	6.43%
Accounts Receivable Turnover Full definition →		8.38	8.47	8.36	7.96
Accounts Payable Turnover Full definition →		4.14	6.57	6.16	3.12
Inventory Turnover Full definition →		1.88	3.14	3.43	3.45
Average Days of Payables Full definition →		93.85	44.72	47.86	161.09
Days of Inventory on Hand Full definition →		125.57	142.19	123.39	117.01
Tax Rate Full definition →		(0.05)	1.81	2.26	2.14
Research and Development Expense of Revenue Full definition →		32.93%	30.69%	29.89%	29.07%
Selling, General and Administrative Expense of Revenue Full definition →		49.98%	51.23%	54.19%	54.48%
Share Based Compensation of Revenue Full definition →		4.71%	4.87%	5.06%	5.10%
Operating CF/Net income Full definition →		0.76	0.28	0.33	0.42
Depreciation/Fixed assets Full definition →		1.75	0.84	0.55	0.57
Capex/Depreciation Full definition →		(30.70)	(0.81)	(1.23)	(1.51)
Revenue per Share Full definition →		6.20	6.36	6.42	6.64
Operating CF per Share Full definition →		1.18	0.65	0.72	0.93
Capex per Share Full definition →		(1.18)	(0.03)	(0.06)	(0.09)
Capex to Sales Full definition →		0.19	0.00	0.01	0.01

Fold the line items

Columns are period end dates

Stockrow Weekly